Exact Mass: 362.1882
Exact Mass Matches: 362.1882
Found 177 metabolites which its exact mass value is equals to given mass value 362.1882
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
17,21-Epoxy-9-fluoro-11beta-hydroxyprogesterone
N-(4-Fluorophenyl)-4,5-dimethyl-6-[(1S)-1-methyl-3,4-dihydro-1H-isoquinolin-2-YL]pyrimidin-2-amine
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent
9R-(beta-D-glucopyranosyloxy)-cis-cascarillic acid|parisveroside A
Ala Ala Thr Thr
Ala Ser Ser Val
Ala Ser Val Ser
Ala Thr Ala Thr
Ala Thr Thr Ala
Ala Val Ser Ser
Gly Ile Ser Ser
Gly Leu Ser Ser
Gly Ser Ile Ser
Gly Ser Leu Ser
Gly Ser Ser Ile
Gly Ser Ser Leu
Gly Ser Thr Val
Gly Ser Val Thr
Gly Thr Ser Val
Gly Thr Val Ser
Gly Val Ser Thr
Gly Val Thr Ser
Ile Gly Ser Ser
Ile Ser Gly Ser
Ile Ser Ser Gly
Leu Gly Ser Ser
Leu Ser Gly Ser
Leu Ser Ser Gly
Ser Ala Ser Val
Ser Ala Val Ser
Ser Gly Ile Ser
Ser Gly Leu Ser
Ser Gly Ser Ile
Ser Gly Ser Leu
Ser Gly Thr Val
Ser Gly Val Thr
Ser Ile Gly Ser
Ser Ile Ser Gly
Ser Leu Gly Ser
Ser Leu Ser Gly
Ser Ser Ala Val
Ser Ser Gly Ile
Ser Ser Gly Leu
Ser Ser Ile Gly
Ser Ser Leu Gly
Ser Ser Val Ala
Ser Thr Gly Val
Ser Thr Val Gly
Ser Val Ala Ser
Ser Val Gly Thr
Ser Val Ser Ala
Ser Val Thr Gly
Thr Ala Ala Thr
Thr Ala Thr Ala
Thr Gly Ser Val
Thr Gly Val Ser
Thr Ser Gly Val
Thr Ser Val Gly
Thr Thr Ala Ala
Thr Val Gly Ser
Thr Val Ser Gly
Val Ala Ser Ser
Val Gly Ser Thr
Val Gly Thr Ser
Val Ser Ala Ser
Val Ser Gly Thr
Val Ser Ser Ala
Val Ser Thr Gly
Val Thr Gly Ser
Val Thr Ser Gly
Prolylleucine
Prolylleucine is a dipeptide containing branched-chain amino acids. Prolylleucine can affect the circadian rhythms and behaviour of animals[1][2].
EPOXYPROPOXYPROPYL TERMINATED POLYDIMETHYLSILOXANE
4-(4-propylcyclohexyl)-4-(trifluoromethoxy)-1,1-biphenyl
[1-(2,3-Dihydro-benzo[1,4]dioxine-2-carbonyl)-piperidin-4-yl]-carbaMic acid tert-butyl ester
(R)-2,3-Dimethyl-4-(triphenylphosphoranylidene)-2-butanol
1-[4-[1-(3-methoxy-4-nitrophenyl)piperidin-4-yl]piperazin-1-yl]ethanone
4-[3-Oxo-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-YL)-propenyl]-benzoic acid
(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxypropanoyl]amino]pentanedioic acid
(6S)-6-Cyclopentyl-6-[2-(3-fluoro-4-isopropoxyphenyl)ethyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one
(3r)-3-Hydroxy-2,2-Dimethyl-4-Oxo-4-({3-Oxo-3-[(2-Sulfanylethyl)amino]propyl}amino)butyl 2,2-Dimethylpropanoate
(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid
2,4-Dimethyl-5-furo[3,2-b]pyrrolecarboxylic acid [3-methyl-1-oxo-1-(2-oxolanylmethylamino)butan-2-yl] ester
17,21-Epoxy-9-fluoro-11-hydroxypregn-4-ene-3,20-dione, (11beta)-
methyl (2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-(oxan-4-ylmethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylate
N-[2-[(2R,5S,6R)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[2-[(2R,5R,6S)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[2-[(2S,5S,6S)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]propanamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]propanamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]propanamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-1-(4-oxanylmethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
N-[2-[(2S,5R,6S)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[2-[(2R,5R,6R)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[2-[(2R,5S,6S)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[2-[(2S,5S,6R)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[2-[(2S,5R,6R)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]propanamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]propanamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]propanamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]propanamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]propanamide
revaprazan
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent
2-[({6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl}methyl)amino]-3-(c-hydroxycarbonimidoyl)propanoic acid
(2E,6E)- 3,7,11-trimethyl-9-(phenylsulfonyl)-2,6,10-dodecatrien-1-ol
{"Ingredient_id": "HBIN005569","Ingredient_name": "(2E,6E)- 3,7,11-trimethyl-9-(phenylsulfonyl)-2,6,10-dodecatrien-1-ol","Alias": "NA","Ingredient_formula": "C21H30O3S","Ingredient_Smile": "CC(=CC(CC(=CCCC(=CCO)C)C)S(=O)(=O)C1=CC=CC=C1)C","Ingredient_weight": "362.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41632","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5368759","DrugBank_id": "NA"}